|
|
 |
|
Viewing report
|
|
|
|
Strategic Analysis of the European Molecular Diagnostics Market
Frost & Sullivan, June 2005
With growing levels of technological automation and throughput processing rates, molecular diagnostics has been recognized as one of the fastest growing markets in the European in vitro diagnostics (IVD) industry. Its ability to sensitively and distinctly detect the primary cause of diseases is unprecedented in medicine. These tests seek to supplement or replace traditional laboratory tests and established standards of care and clinical utility. However, molecular diagnostics have to undergo clinical tests and trials to demonstrate that the information provided by them improves the quality of decision-making and patient care by physicians.
This Frost & Sullivan research service provides an overview of and an outlook for the molecular diagnostics markets in Europe, detailing revenue forecasts by region and providing market share analyses. The study defines molecular diagnostics to include diagnosis of infectious diseases, cancer and pharmacogenomics. The information offered by this exhaustive study can prove valuable to both large and small participants seeking to position themselves in these highly competitive markets.
|
|
|
|
